Sector: Health Care
Director information for OLEMA PHARMACEUTICALS INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Andrew Rappaport | Director | 68 | [] | ["Audit","Compensation"] | 2026 |
| Cynthia Butitta | Director | 71 | [] | ["Audit","Compensation"] | 2026 |
| Cyrus Harmon, Ph.D. | [] | ["Science and Technology"] | 2026 | ||
| Cyrus L. Harmon, Ph.D. | Director | 55 | [] | [] | 2026 |
| David C. Myles, Ph.D. | Chief Scientific Officer | 64 | [] | [] | 2026 |
| Gorjan Hrustanovic, Ph.D. | Director | 37 | [] | ["Compensation","Science and Technology"] | 2026 |
| Graham Walmsley, M.D., Ph.D. | Director | 39 | [] | ["Audit"] | 2026 |
| Ian Clark | Chairperson of the Board | 65 | [] | ["Compensation"] | 2026 |
| Naseem Zojwalla, M.D. | Chief Medical Officer | 53 | [] | [] | 2026 |
| Prakash Raman | Ph.D.(1) | [] | [] | 2026 | |
| Prakash Raman, Ph.D. | Director | 56 | [] | [] | 2026 |
| Sandra Horning, M.D. | FACP, FASCO | [] | ["Science and Technology","Compensation"] | 2026 | |
| Sandra Horning, M.D. | Director | 77 | [] | [] | 2026 |
| Scott Garland | Director | 57 | [] | ["Compensation"] | 2026 |
| Sean Bohen, M.D., Ph.D. | Director, President and Chief Executive Officer; President, Chief Executive Officer and Director | 59 | [] | [] | 2026 |
| Yi Larson | Director | 46 | [] | ["Compensation"] | 2026 |
